SAN FRANCISCO — The U.S. Court of Appeals for the Federal Circuit has turned down a pharmaceutical company’s plea to elevate a forum selection clause above judicial economy in assigning a patent case.
Despite recent signals from the Supreme Court about respecting forum selection clauses, the Federal Circuit summarily denied a 42-page petition for writ of mandate by Eli Lilly & Co. seeking to keep its case against Genentech and City of Hope in the Northern District of California, rather than having it sent to U.S. District Judge Mariana Pfaelzer of Los Angeles.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
